PURLs: Aneuploidy screening: Newer noninvasive test gains traction
- PMID: 26845165
- PMCID: PMC4756029
PURLs: Aneuploidy screening: Newer noninvasive test gains traction
Abstract
Favorable results from the 2 studies reviewed here have prompted ACOG to recommend that cell-free DNA screening be discussed with all pregnant patients.
Similar articles
-
Noninvasive prenatal detection of aneuploidy.Clin Obstet Gynecol. 2014 Mar;57(1):210-25. doi: 10.1097/GRF.0000000000000016. Clin Obstet Gynecol. 2014. PMID: 24351443 Review.
-
SMFM Statement: clarification of recommendations regarding cell-free DNA aneuploidy screening.Am J Obstet Gynecol. 2015 Dec;213(6):753-4. doi: 10.1016/j.ajog.2015.09.077. Epub 2015 Oct 14. Am J Obstet Gynecol. 2015. PMID: 26458766
-
Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy.Obstet Gynecol. 2012 Dec;120(6):1532-4. doi: 10.1097/01.AOG.0000423819.85283.f4. Obstet Gynecol. 2012. PMID: 23168792
-
Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.JAMA. 2015 Jul 14;314(2):162-9. doi: 10.1001/jama.2015.7120. JAMA. 2015. PMID: 26168314
-
Fetal aneuploidy detection by maternal plasma DNA sequencing: a technology assessment.Prenat Diagn. 2013 Jun;33(6):514-20. doi: 10.1002/pd.4109. Prenat Diagn. 2013. PMID: 23686655 Review.
Cited by
-
Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD011767. doi: 10.1002/14651858.CD011767.pub2. Cochrane Database Syst Rev. 2017. PMID: 29125628 Free PMC article.
References
-
- Bianchi DW, Parker RL, Wentworth J, et al; CARE Study Group. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med. 2014;370:799–808. - PubMed
-
- Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372:1589–1597. - PubMed
-
- Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol. 2011;204:205.e1–11. - PubMed
-
- Bianchi DW, Platt LD, Goldberg JD, et al; MatERNal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119:890–901. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources